Novel Psychoactive Substances (eBook)
XXII, 178 Seiten
Springer International Publishing (Verlag)
978-3-319-60600-2 (ISBN)
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments.
Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and p
Dr. Ornella Corazza is a Reader in Substance Addictions and Behaviours at University of Hertfordshire and leading expert in the field of Novel Psychoactive Substances (NPS). She has published numerous papers in the field and her work has been recognized and prized internationally, including with the 2013 European Health Award. She has previously held Fellowships at the University of Padua (Italy), University of Bochum (Germany), University of London (SOAS; King's College) and at the Centre of Excellence on Death and Life Studies at the University of Tokyo (Japan). She is also a Visiting Professor at Sapienza University of Rome. As a consequence of working internationally in different academic environments, she has developed a unique specialism in the combined fields of health, culture and legislation. In total, Dr Corazza is author of over 200 journal articles, book chapters and conference papers. They cover the main classes of NPS as well new methods for the rapid identifica
tion of novel drug trends, prevention and policy recommendations.Dr Andres Roman-Urrestarazu combined expertise in psychiatry, mental health and health economics allowed him to make original contributions in the fields of substance abuse where he has developed a growing body of research in the field of NPS Policy. He is Assistant Professor at Maastricht University Department of International Health and concurrently holds the Gilling's Fellowship in Global Public Health at the Institute of Public Health (IPH), University of Cambridge and the Institut Louis Pasteur (ILP) Paris. He currently co-supervises PhD students at the IPH in Cambridge and Maastricht University Department of International Health where he leads a project that studies the association between austerity, macroeconomic indicators and substance misuse. Concurrently with this policy agenda, his clinical work and research is based in the Autism Research Centre, Department of Psychiatry, University of Ca
mbridge where he works on neurodevelopment disorders and more specifically ASD, disability, inequality and social policy. He has previously held appointments as Research Officer in Health Economics and Health Policy at LSE Health, London School of Economics and Political Science working extensively in the Middle East on behavioural risk factors for metabolic disease in collaboration with WHO, GIZ/GTZ and ILO among others, while also developing a teaching career in Trinity Hall, Cambridge where he was Director of Studies in Psychology and Behavioral Science. He has also worked in different government roles around the world having worked as Technical Lead at the Centre for Health Technology Evaluation (CHTE) in the National Institute for Health and Care Excellence and also as Medical Advisory Staff at the Ministry of Health Chile - MINSAL. He has published several papers in relation to NPS while also submitting evidence to the House of Commons for the 2016 UK PSA. In that occasion, he assisted the discussion around NPS with a comparative policy analysis, while also managing the engagement with the press for the dissemination of this evidence. His latest book, in co-authorship with Dr Ornella Corazza, discusses different global policy options for NPS having collaborated for this work with different international organisations such as the European Commission, UNODC, DEA, WADA, LSE Ideas, and various leading academics in the field of drug policy. Dr Andres Roman-Urrestarazu specialises in Psychiatry (MD and BM in Medicine, University of Santiago de Chile; PhD Psychiatry, University of Cambridge), Health Economics and Policy (MSc London School of Economics).Dr. Ornella Corazza is a Reader in Substance Addictions and Behaviours at University of Hertfordshire and leading expert in the field of Novel Psychoactive Substances (NPS). She has published numerous papers in the field and her work has been recognized and prized internationally, including with the 2013 European Health Award. She has previously held Fellowships at the University of Padua (Italy), University of Bochum (Germany), University of London (SOAS; King’s College) and at the Centre of Excellence on Death and Life Studies at the University of Tokyo (Japan). She is also a Visiting Professor at Sapienza University of Rome. As a consequence of working internationally in different academic environments, she has developed a unique specialism in the combined fields of health, culture and legislation. In total, Dr Corazza is author of over 200 journal articles, book chapters and conference papers. They cover the main classes of NPS as well new methods for the rapid identification of novel drug trends, prevention and policy recommendations.Dr Andres Roman-Urrestarazu combined expertise in psychiatry, mental health and health economics allowed him to make original contributions in the fields of substance abuse where he has developed a growing body of research in the field of NPS Policy. He is Assistant Professor at Maastricht University Department of International Health and concurrently holds the Gilling’s Fellowship in Global Public Health at the Institute of Public Health (IPH), University of Cambridge and the Institut Louis Pasteur (ILP) Paris. He currently co-supervises PhD students at the IPH in Cambridge and Maastricht University Department of International Health where he leads a project that studies the association between austerity, macroeconomic indicators and substance misuse. Concurrently with this policy agenda, his clinical work and research is based in the Autism Research Centre, Department of Psychiatry, University of Cambridge where he works on neurodevelopment disorders and more specifically ASD, disability, inequality and social policy. He has previously held appointments as Research Officer in Health Economics and Health Policy at LSE Health, London School of Economics and Political Science working extensively in the Middle East on behavioural risk factors for metabolic disease in collaboration with WHO, GIZ/GTZ and ILO among others, while also developing a teaching career in Trinity Hall, Cambridge where he was Director of Studies in Psychology and Behavioral Science. He has also worked in different government roles around the world having worked as Technical Lead at the Centre for Health Technology Evaluation (CHTE) in the National Institute for Health and Care Excellence and also as Medical Advisory Staff at the Ministry of Health Chile - MINSAL. He has published several papers in relation to NPS while also submitting evidence to the House of Commons for the 2016 UK PSA. In that occasion, he assisted the discussion around NPS with a comparative policy analysis, while also managing the engagement with the press for the dissemination of this evidence. His latest book, in co-authorship with Dr Ornella Corazza, discusses different global policy options for NPS having collaborated for this work with different international organisations such as the European Commission, UNODC, DEA, WADA, LSE Ideas, and various leading academics in the field of drug policy. Dr Andres Roman-Urrestarazu specialises in Psychiatry (MD and BM in Medicine, University of Santiago de Chile; PhD Psychiatry, University of Cambridge), Health Economics and Policy (MSc London School of Economics).
1.The Global Emergence of NPS: An Analysis of a New Drug Trend.- 2.Legislating NPS in the European Union.- 3.Regulation as Global Drug Governance – How New is the NPS Phenomenon?.- 4.Anti-Doping Challenges with Novel Psychoactive Substances in Sport.- 5.Exploring Novel Policy Responses to NPS and ‘legal highs’ in New Zealand, Poland, Republic of Ireland and the United Kingdom.- 6.Regulating NPS in the Middle East: A Critical Juncture.- 7.Finding Novel Policy Response to the Challenge of NPS in Kazakhstan: Reconsidering Existing Policy and the Work of Health Professionals.- 8.NPS Policy Pitfalls: The Implementation and Management Challenges Within the Prison, Police and Health Services in the United Kingdom.- 9.NPS: An Opportunity to Move From Blanket Prohibition to a More Functionalist Approach?.- 10.The Challenges in Interpreting National-Level Strategic Indicators: A Drug Enforcement Administration Analyst’s Perspective.- 11.Harmonizing NPS Legislation Across the European Union: An Utopia?.- 12.New psychoactive substances: The Regulatory Experience and Assessment of Options.
| Erscheint lt. Verlag | 9.8.2017 |
|---|---|
| Zusatzinfo | XXII, 178 p. 8 illus., 6 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Themenwelt | Wirtschaft ► Volkswirtschaftslehre |
| Schlagworte | cyber crime • Drug policy • drug trafficking • Illicit Drug Market • New Psychoactive Substances • NPS Policy • Public Health • Substance Abuse Research |
| ISBN-10 | 3-319-60600-X / 331960600X |
| ISBN-13 | 978-3-319-60600-2 / 9783319606002 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 2,9 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
